SINGLE-DOMAIN ANTIBODY TARGETING 4-1BB, FUSION PROTEIN THEREOF, PHARMACEUTICAL… Application WO-2022057875-A1 World Intellectual Property Organisation (WIPO) 24 Mar 2022